Inventiva SA header image

Inventiva SA

IVA

Equity

ISIN FR0013233012 / Valor 35598121

Euronext - Euronext Paris (2026-07-16)

EUR 3.83-1.16%

Inventiva SA
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Inventiva SA is a clinical-stage biopharmaceutical company based in France, publicly traded on Euronext, that discovers and develops oral small-molecule therapies aimed primarily at liver, fibrotic and metabolic diseases and certain rare genetic disorders. Its most advanced program is lanifibranor (IVA337), a pan-PPAR agonist being developed as a treatment for non-alcoholic steatohepatitis (NASH), and the company also pursues drug candidates for lysosomal storage and muscle-related conditions. Inventiva advances compounds through preclinical and clinical studies and seeks collaborations and licensing arrangements to support development and potential commercialization.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

38.6%1Y

3.24%3Y

-67.9%5Y

Performance

63.3%1Y

61.6%3Y

62.4%5Y

Volatility

909 M

Market cap (USD)

194,994

Daily traded volume (Shares)

/

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Dyne Therapeutics Inc

Dyne Therapeutics Inc Valor: 56806425

Annual Return

-50%0%+50%

Risk level

110

4.49%USD 23.74

Kenvue Inc

Kenvue Inc Valor: 124280948

Annual Return

-50%0%+50%

Risk level

110

-0.21%USD 18.98

OKYO Pharma Limited

OKYO Pharma Limited Valor: 127195533

Annual Return

-50%0%+50%

Risk level

110

3.62%USD 1.43

Herbalife Ltd

Herbalife Ltd Valor: 2002103

Annual Return

-50%0%+50%

Risk level

110

-3.07%USD 11.99

Novo Nordisk A/S

Novo Nordisk A/S Valor: 129508879

Annual Return

-50%0%+50%

Risk level

110

-1.76%DKK 329.90

Neumora Therapeutics Inc

Neumora Therapeutics Inc Valor: 129329732

Annual Return

-50%0%+50%

Risk level

110

0.63%USD 1.61

SCHOTT Pharma AG & Co. KGaA

SCHOTT Pharma AG & Co. KGaA Valor: 128964250

Annual Return

-50%0%+50%

Risk level

110

0.99%EUR 20.50

Sandoz Group Ltd

Sandoz Group Ltd Valor: 124359842

Annual Return

-50%0%+50%

Risk level

110

3.14%CHF 65.74

Aurora Cannabis Inc

Aurora Cannabis Inc Valor: 132838450

Annual Return

-50%0%+50%

Risk level

110

1.65%CAD 3.70

CG Oncology Inc

CG Oncology Inc Valor: 131996952

Annual Return

-50%0%+50%

Risk level

110

3.38%USD 71.85

SIX

FactSet

Clearbit

Logos provided by Clearbit